The Christie NHS Foundation Trust

The Christie NHS Foundation Trust Please note this account is only monitored 9am – 5pm Monday to Friday (not Bank Holidays). These services help increase income for our NHS developments.

The Christie is one of Europe’s leading cancer centres, treating more than 44,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester and Cheshire, but as a national specialist around 26% patients are referred to us from other parts of the country. Our annual turnover is £173 million and we have 2,500 staff, 350 volunteers and 18,000 public m

embers. NHS services
We provide:
• radiotherapy through one of the largest radiotherapy departments in the world, both on our main site in south Manchester and via The Christie radiotherapy centre in Oldham
• chemotherapy in the largest chemotherapy unit in the UK and via 14 other hospitals
• highly specialist surgery for complex and rare cancer
• a wide range of support and diagnostic services

Research & Education
We are also an international leader in research, with world first breakthroughs for over 100 years. Our clinical trials unit is the largest early phase trials unit in the world, with around 200 trials ongoing at any one time. We are part of the Manchester Cancer Research Centre with The University of Manchester and Cancer Research UK and also one of seven partners in the Manchester Academic Health Science Research Centre. Cancer research in Manchester has been officially ranked the best in the UK. The Christie School of Oncology provides undergraduate education, clinical professional and medical education and is the first of its kind in the UK. Joint ventures
We provide private patient services through The Christie Clinic, our joint venture with HCA International. Developments
Our developments are breaking new ground and transforming treatment and care for cancer patients. These include a unique network of Christie radiotherapy centres in other parts of the area to deliver treatment closer to people’s homes and the development of our young oncology services in partnership with the Teenage Cancer Trust. History
We have achieved world firsts since The Christie was established in 1901. It was named The Christie in recognition of the pioneering work of both Richard Copley Christie and his wife Mary Ellen Christie. At this time there were 30 beds and 463 patients a year. Charity
Our charity is the second largest hospital charity in the country. Over 2,000 fundraisers and 20,000 supporters help bring in £15.9 million a year, which helps fund additional patient services and vital research. To find ‘The Christie charity’ on facebook please follow this link

64-year-old Penny was diagnosed with blood cancer in August 2024. She had chemotherapy followed by a stem-cell transplan...
14/06/2026

64-year-old Penny was diagnosed with blood cancer in August 2024. She had chemotherapy followed by a stem-cell transplant at The Christie and is currently in remission.

Penny, who worked in the NHS for over 30 years and has been married to Alan for 44 years, was diagnosed after going to A&E after getting hit on the leg.

“I arrived at my local hospital at 8.30 in the morning, and by 8.30 at night I was being treated at The Christie. It all happened so quickly, I didn’t have time to take it in. I ended up being in for seven weeks, having several different types of chemo."

Penny’s treatment was successful, but she needed a stem-cell transplant to replace her damaged blood cells with healthy stem cells from a donor. In Penny’s case, the donated cells were collected from the umbilical cords of two babies after they had been safely born.

“I started the transplant process on New Year’s Eve in 2024, which brought a whole new meaning to the phrase ‘new year, new me.’ I had to stay in for 7 weeks. Not long after I was discharged, I got a chest infection and was hospitalised once again. The infection really wiped me out; I’ve never been so tired in my life, but thankfully I didn’t have too many other side effects.”

Penny’s stem cell transplant was successful, and she has recently moved from having check-ups every month to every two months.

“My recovery hasn’t been linear – there have been a few bumps along the road, but I’m back to doing the things I love now, like going to the gym and spending time with friends and family. I’m starting to look at what my life will look like beyond cancer,” Penny says. "I'm so grateful to the donors' families for donating the cords so I could live."

"Lots of people also receive stem cells from adult donors. This World Blood Donor Day, and every day, I would encourage anyone who can to sign up to donate blood and stem cells," she adds.

13/06/2026

The resident doctors' strike that was due to start on Monday has now been called off.

Please continue to attend any appointments as planned and access NHS services as normal if you need them.

Resident doctors at The Christie are striking from 7am on Monday, 15 June to 7am on Friday, 19 June.We're preparing ahea...
10/06/2026

Resident doctors at The Christie are striking from 7am on Monday, 15 June to 7am on Friday, 19 June.

We're preparing ahead of the action to help maintain safe care and minimise disruption as much as possible.

As with previous periods of industrial action, patients will be contacted directly if their appointments need to be rescheduled.

A new drug being trialled at The Christie has the potential to make immunotherapy effective where it hasn't been before....
09/06/2026

A new drug being trialled at The Christie has the potential to make immunotherapy effective where it hasn't been before.

Immunotherapies harness the body's immune system to find and attack cancer cells.

The pill, currently called GRWD5769, has shown promise in shrinking tumours or keeping them stable in six advanced and hard-to-treat cancers - cervical, bladder, liver, non-small cell lung cancer, squamous cell carcinoma of the head and neck and a type of bowel cancer called microsatellite stable bowel cancer.

Every patient who benefitted had already failed treatment, and most had no conventional treatment options left after multiple lines. Crucially, immunotherapy hadn't worked or had stopped working.

Some people on the EMITT-1 trial saw their tumours shrink by 30% or more.

The drug works by targeting an enzyme called ERAP1, which cancer cells use to hide from the immune system.

When paired with Cemiplimab, an existing immunotherapy, it frees up the patient’s immune system to allow it to target the cancer on its own.

💬Professor Fiona Thistlethwaite, Consultant Medical Oncologist, is leading the trial at The Christie:

“Immunotherapy has been a game-changer in the way we treat cancer, but the number of people that can benefit is still relatively low.

“What excites me about this trial is the combination of what we’re seeing - strong signals of efficacy across six tumour types that have shown great resistance to immunotherapy, with very few side effects. That's unusual at such an early stage when we’re usually just looking at how safe it is.

“There’s a lot more work to be done before it reaches the clinic, but for a brand-new drug to show that kind of profile so early, and in so many different types of hard-to-treat cancers, gives me genuine optimism.”

07/06/2026

During her visit to The Christie, The Princess of Wales chatted to patients and staff across the hospital.

These personal conversations meant so much to everyone who spoke to her.

20-year-old Maison Shaw, who met Her Royal Highness in our Teenage and Young Adult unit, said:

💬 "It means a lot to speak to people like The Princess because they actually understand what it's like to go through all the tough treatments and how you actually feel alongside the treatments and how rough they can be."

Thank you so much to Her Royal Highness for visiting our hospital, and to all the patients and staff involved.

Her Royal Highness The Princess of Wales came to our Withington site today.  The visit focused on how we support people’...
04/06/2026

Her Royal Highness The Princess of Wales came to our Withington site today.

The visit focused on how we support people’s physical, mental, emotional, and spiritual wellbeing while they’re going through cancer treatment.

Her Royal Highness first met patients having chemotherapy at the Oak Road Treatment Centre, including Claire, who had just rung the end-of-treatment bell.

She then took a tour of the hospital and garden, chatting with patients who have benefited from our complementary therapy, art, and spiritual care services, as well as with the staff involved.

The Princess rounded off the day by visiting the Teenage and Young Adult (TYA) unit to speak to staff, young patients , and their families about the social and recreational activities designed to support young people as they navigate an especially challenging time.

💬Roger Spencer, our CEO, comments:

“We were delighted to welcome Her Royal Highness The Princess of Wales.

“Having cancer affects every area of someone’s life, and we’re proud to have a person-centred approach to care that focuses on the individual, and not just their diagnosis.

“Our art room, complementary therapy service and TYA unit mean so much to people here, and it was an honour to introduce The Princess to the patients and staff involved.”

Aileen Pritchard was able to avoid having chemotherapy for breast cancer thanks to an experimental gene test she had at ...
03/06/2026

Aileen Pritchard was able to avoid having chemotherapy for breast cancer thanks to an experimental gene test she had at The Christie. 🧬

The OPTIMA study evaluated the effectiveness of the Prosigna test, which assesses the activity of genes involved in breast cancer growth.

The results suggest that people aged 40 and over whose tumours have a low Prosigna test score can be treated safely with hormone therapy alone, potentially transforming care for thousands of patients each year.

Of the 4,429 people who took part in the trial, more than two-thirds (68%) had a low score.

For this group, the results showed that outcomes were very similar whether chemotherapy was given or not.

The trial recruited people aged 40 or older following surgery for hormone-sensitive breast cancer. Most had their cancer spread to underarm lymph nodes, which placed them at high risk of future recurrence.

Results for the full trial population will inform decision-making on whether the test will be made available on the NHS.

💬 Reflecting on her experience of the trial, Aileen says:

“If I had to have chemotherapy, I probably would have had to stop working, and we might have lost our livelihood, which would have been disastrous. I can still picture where I was and how I felt when the nurse told me the news – I could almost feel the weight lifting off my shoulders. It was a huge relief.

“Being able to live the best life possible during cancer treatment is so important for both your physical and mental health. I was able to do all the things I love, like going swimming three to four times a week and getting away for the weekend with Kevin.

“It’s great that the results show that this test works, and I hope that more people will be able to benefit from it in the future. I had no reservations about joining the trial. Science and medicine can’t advance without research, so I was glad to play my part in helping people like me in the future.”

"What does volunteering mean to you?"This National Volunteers' Week, some of our volunteers are sharing what they love a...
01/06/2026

"What does volunteering mean to you?"

This National Volunteers' Week, some of our volunteers are sharing what they love about their roles.

Thank you to all our volunteers for the invaluable contribution you make to our hospital.

Find out more about volunteering at The Christie.👇

Looking for a new challenge?We have a range of clinical and non-clinical roles available at The Christie. Here are just ...
30/05/2026

Looking for a new challenge?

We have a range of clinical and non-clinical roles available at The Christie. Here are just a few of them:

🩵Receptionist
🩵Haematology Scheduler
🩵Advanced practice therapeutic radiographer
🩵Clinical Nurse Specialist
🩵Clinical Fellow in Medical Oncology

Find out more and apply on our website.👇

Doctor-in-training Charlotte Russell has paused her medical studies to do a PhD in cancer research. 🔬  Based at the Manc...
28/05/2026

Doctor-in-training Charlotte Russell has paused her medical studies to do a PhD in cancer research. 🔬

Based at the Manchester Cancer Research Centre on the Christie site in Withington, she’s looking into why people under 60 are more likely to have cancer that spreads to the brain than older adults.

Charlotte, who wants to be an oncologist when she finishes her training, recently spent time with two Christie consultants and their patients in the clinic.

“I was so impressed with the all-encompassing and compassionate nature of the care at The Christie. I was in the oesophageal cancer clinic, so in addition to the consultant and nurse, patients also got support from other experts like dieticians. It was great to see how everything works,” she says.

“Spending time in the hospital itself helped to bring home why cancer research is so crucial. It helps you understand the patient experience and how your own research can improve lives,” she says. “It has motivated me to pursue a career as an oncologist involved in research once I’ve qualified.”

Address

550 Wilmslow Road
Manchester
M204BX

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+441614463000

Alerts

Be the first to know and let us send you an email when The Christie NHS Foundation Trust posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organisation

Send a message to The Christie NHS Foundation Trust:

Share